| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/18/2010 | EP2217258A1 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent |
| 08/18/2010 | EP2217234A2 Combinations of mek inhibitors with mtor inhibitors |
| 08/18/2010 | EP2217227A2 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 08/18/2010 | EP2217073A1 Method of treating metabolic disorders and depression with dopamine receptor agonists |
| 08/18/2010 | EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 08/18/2010 | EP1443899B1 Bowel cleansing agent |
| 08/18/2010 | EP1420025B1 Powder comprising water-containing beta-maltose crystals and production process and use thereof |
| 08/18/2010 | EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 08/18/2010 | EP1140009B2 Absorbent article composition and use thereof for sequestering skin irritants. |
| 08/18/2010 | EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 08/18/2010 | CN1980647B Formulation comprising histone deacetylase inhibitor |
| 08/18/2010 | CN1835752B Multivitamin syrup for children or young adults |
| 08/18/2010 | CN1726039B Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 08/18/2010 | CN1704121B Anti-angiogenic compositions and methods of use |
| 08/18/2010 | CN101808666A Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| 08/18/2010 | CN101808665A Pharmaceutical combination of aliskiren and valsartan |
| 08/18/2010 | CN101808664A Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 08/18/2010 | CN101808648A Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 08/18/2010 | CN101808646A Agent for improving motor complications or psychiatric symptoms in parkinson's disease |
| 08/18/2010 | CN101808643A Preparation for the treatment of equine laminitis |
| 08/18/2010 | CN101808636A Treatment of melanoma |
| 08/18/2010 | CN101808631A galenical formulations of organic compounds |
| 08/18/2010 | CN101808627A antiseptics |
| 08/18/2010 | CN101804205A Use of VEGF antibody and VEGF receptor antagonist in preparation of pain-killing vaccine or medicament |
| 08/18/2010 | CN101804204A Novel method for treating infertility caused by chronic pelvic inflammation by combining traditional Chinese medical science with western medical science |
| 08/18/2010 | CN101804197A Medicament compound for treating cancer bone metastasis and purposes thereof |
| 08/18/2010 | CN101804064A Application of dihydroquercetin and glucoside compounds to preparing drug-resistance bacteria medicine |
| 08/18/2010 | CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/17/2010 | US7777069 Prodrugs of carbamate inhibitors of IMPDH |
| 08/17/2010 | US7776921 Treating benign prostate hyperplasia with SARMS |
| 08/17/2010 | US7776899 Mixture of phentolamine mesylate, papaverine hydrochloride and alprostadil with buffer; injecting into penis |
| 08/17/2010 | US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
| 08/17/2010 | US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders |
| 08/17/2010 | US7776863 administering therapeutically effective amount of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine or salt thereof, with at least one other agent used for treatment of AIDS or HIV such as didanosine, delavirdine, ritonavir, enfuvirtide |
| 08/17/2010 | US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases) |
| 08/17/2010 | US7776846 Administering a synergistic mixture of a cortisone, hydrocortisone and/or prednisolone derivative; antiasthmatic agents; side effect reduction |
| 08/17/2010 | US7776845 Pharmaceutical compositions |
| 08/17/2010 | US7776838 such as AZT; derivatives of uridine or cytidine such as triacetyluridine and ethoxycarbonyluridine or triacetylcytidine, capable of attenuating damage to hematopoietic system in animals; interleukins; colony stimulating factors |
| 08/17/2010 | US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin |
| 08/17/2010 | US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 08/17/2010 | US7776541 Psoriasin expression by breast epithelial cells |
| 08/17/2010 | US7776527 identifying a test agent as reducing apoptosis of a macrophage cell; reducing the activity of Protein Kinase R |
| 08/17/2010 | US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH) |
| 08/17/2010 | US7776519 detection of mesenchymal tumoral cells by using the Slug (zinc fingers domains) gene; biomarker |
| 08/17/2010 | US7776354 Remedies for glomerular diseases |
| 08/17/2010 | US7776347 Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of hydrophobic material separate from the structured benefit agent |
| 08/17/2010 | US7776346 Personal product compositions comprising structured benefit agent premix or delivery vehicle |
| 08/17/2010 | US7776338 useful for enhancing immune response to antigens; lack ganglioside binding activity; applicable to mucosal immunization in humans |
| 08/17/2010 | US7776337 novel lactic acid-producing strains; Lactobacillus acidophilus; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry |
| 08/17/2010 | US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk |
| 08/17/2010 | US7776319 Methods and compositions for treatment of ion imbalances |
| 08/17/2010 | US7776315 Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| 08/17/2010 | US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 08/17/2010 | CA2557538C Benzimidazole derivative and use as an angiotensin ii receptor antagonist |
| 08/17/2010 | CA2530216C The use of an edible acid or the potassium or sodium salt thereof in the treatment of allergy |
| 08/17/2010 | CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 08/17/2010 | CA2472372C Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| 08/17/2010 | CA2467065C Preparation for improving the action receptors to neurotransmitters and/or neuromodulators |
| 08/17/2010 | CA2444980C Single dose aromatase inhibitor for treating infertility |
| 08/17/2010 | CA2444867C Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 08/17/2010 | CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 08/17/2010 | CA2408301C Methods of pre-selecting a polymerizable fluid formed into an intraocular lens |
| 08/17/2010 | CA2383814C Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 08/17/2010 | CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide |
| 08/17/2010 | CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 08/12/2010 | WO2010091299A2 Novel combination cancer therapies |
| 08/12/2010 | WO2010091280A1 N-halogenated amino acid formulations comprising phosphine or amine oxides |
| 08/12/2010 | WO2010090614A1 Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form |
| 08/12/2010 | WO2010090613A1 The combined pharmaceutical composition in a single dosage form |
| 08/12/2010 | WO2010089391A1 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| 08/12/2010 | WO2010089355A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| 08/12/2010 | WO2010088735A1 Method of producing progenitor cells from differentiated cells |
| 08/12/2010 | WO2010061142A3 Composition containing an angiotensin ii at2 receptor antagonist, intended for slowing cancer cell tumor initiation in a high-risk mammal |
| 08/12/2010 | WO2010036975A3 Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
| 08/12/2010 | US20100204332 Method for treating a disease or condition responsive to opening of c1c-2 channel |
| 08/12/2010 | US20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman |
| 08/12/2010 | US20100204253 Ribosome Structure and Protein Synthesis Inhibitors |
| 08/12/2010 | US20100204190 New combinations |
| 08/12/2010 | US20100204125 Genetic alterations associated with cancer |
| 08/12/2010 | US20100204086 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 08/12/2010 | US20100203542 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 08/12/2010 | US20100203160 Vitamin/Mineral Composition with DHA |
| 08/12/2010 | US20100203147 Viruses for the Treatment of Cellular Proliferative Disorders |
| 08/12/2010 | US20100203087 Chemorepulsion of cells |
| 08/12/2010 | US20100203086 Attack of tumor cells with missing, low or aberrant mhc expression by combining non mhc-restricted t-cells/nk-cells and mhc-restricted cells |
| 08/12/2010 | US20100203053 Method and composition for treating immune complex associated disorders |
| 08/12/2010 | US20100203032 Orlistat compositions |
| 08/12/2010 | US20100203005 Transdermal compositions |
| 08/12/2010 | US20100202989 Methods for treatment of dermatological conditions |
| 08/11/2010 | EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/11/2010 | EP2216334A1 Hiv protease inhibiting sulfonamides |
| 08/11/2010 | EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 08/11/2010 | EP2216033A2 Methods of treating disease by transplantation of allogeneic or xenogeneic organs or tissues |
| 08/11/2010 | EP2216031A1 Buffered Compositions for dialysis |
| 08/11/2010 | EP2216023A1 Condensed pyridine derivative and use thereof |
| 08/11/2010 | EP2214713A1 Memantine protects inflammation-related degeneration of dopamine neurons through inhibition of over-activated microglia and release of neurotrophic factors from astroglia |
| 08/11/2010 | EP2214672A2 Combination analgesic employing opioid and neutral antagonist |
| 08/11/2010 | EP2214671A1 Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs |
| 08/11/2010 | EP2214656A1 Compositions and methods for enhancing immune response |
| 08/11/2010 | EP1515750B1 Combinations comprising epothilones and pharmaceutical uses thereof |